HK2 and hepatocellular carcinoma: In a study of C3H/He mice implanted with MH134 mouse HCC cells and successively treated with 3-BrPA, 3-bromopyruvate (3-BrPA), a HK2 inhibitor [167], mean tumor volume was shown to be significantly reduced [168].